All
Sterling Pharma Solutions Expands Capabilities and Laboratory Capacity
Sterling Pharma Solutions has unveiled a £1 million expansion project to increase its capabilities and laboratories capacity at its Deeside, UK site.
UK Government Awards £15.9 million grant to Chemical Producer Croda
UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.
Twisted Vibrations Enable Quality Control for Chiral Drugs and Supplements
Research from the University of Michigan showed that Terahertz light can be used to probe both the structures of molecular crystals and their twists.
Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation Products
Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.
ViiV Healthcare Announces FDA Approval of Once-Daily Treatment for Children Living with HIV
ViiV Healthcare announced that FDA has approved Triumeq PD, a dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV.
A Future Investment
The AMR Action Fund has made its first investments, marking an important step forward for the partnership to achieve its goal of bringing new treatments to the market for priority pathogens.
Next Level Interrogation
3D cell cultures could provide key avenues to unlocking critical information.
Major League Moves
Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.
Rentschler Biopharma and Vetter Unveil Xpert Alliance
Rentschler Biopharma and Vetter are unveiling a strategic collaboration called Xpert Alliance.
Symbiosis Successfully Completes UK Research and Innovation Project to Enhance Supply Chain for ATMPs
Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.
Thermo Fisher Introduces New Electroporation System for Large-Scale Cell Therapy Development and Manufacturing
Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.
NCI Awards ATCC Task Order to Provide Cancer Epidemiology Services to Research Community
Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.
Research Shows that Junk DNA Encodes Essential Immune and Metabolism Instructions
Researchers from the Telomere-to-Telomere Consortium have discovered new properties about junk DNA that could have wide-reaching implications.
KeyPlants Ships First-of-its-Kind Vaccine Manufacturing Facility to Africa
KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.
Sanofi and IGM Biosciences Announce Collaboration Agreement
Sanofi and IGM Biosciences have announced a collaboration agreement for oncology, immunology, and inflammation targets.
Patent Rights Battles Escalate as Debate over Drug Costs and Access Drags On
Consumer advocates continue to press for initiatives to lower drug prices by revising or reducing patent protections.
Pfizer Issues Voluntary Recall of Blood Pressure Tablets Due to High Levels of Nitrosamine
Pfizer has issued a voluntary nationwide recall on lots of Accuretic tablets due to high levels of nitrosamine.
Novavax and Serum Institute of India Announce Emergency Use Authorization of Novavax’ COVID-19 Vaccine in Adolescents Ages 12 to 18 in India
Novavax’ COVID-19 vaccine has been granted emergency use authorization for use in the adolescent population ages 12–18 in India.
Novartis’ Pluvicto Approved by FDA for Treatment of Advanced Prostate Cancer
FDA has approved Novartis’ targeted radioligand therapy Pluvicto for the treatment of progressive PSMA-positive metastatic castration-resistant prostate cancer.
Orion to Refocus R&D to Cancer and Pain
Orion is planning to refocus its R&D efforts on the development of new proprietary products focused on cancer and pain.
EMA Recommends EU Approval of Roche’s Polivy Combination for Diffuse Large B-Cell Lymphoma
EMA has recommended the approval of Roche’s Polivy plus R-CHP for the treatment of previously untreated diffuse large B-cell lymphoma in the EU.
Empagliflozin Trial Stopped Early Due to Clear Positive Efficacy in People with Chronic Kidney Disease
Boehringer Ingelheim announced Empagliflozin Phase III EMPA_KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease.
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care
Huma has acquired AstraZeneca’s digital health platform, and AstraZeneca has become a shareholder of Huma in a partnership to accelerate digital-first patient care.
Will Decentralized Clinical Trials Become Mainstream?
Pharma’s interest in decentralized clinical trials (DCTs) increases as it helps to expand their geographical reach and racial diversity
FDA Grants Breakthrough Therapy Designation for Pfizer Respiratory Syncytial Virus Vaccine Candidate
Pfizer’s respiratory syncytial virus vaccine candidate has received Breakthrough Therapy Designation from FDA for the prevention of RS in older adults.
EMA Grants Recommendation for New Gene Therapy to Treat Adult Patients with Multiple Myeloma
EMA has recommended a conditional marketing authorization for a new gene therapy to treat adult patients with multiple myeloma.
DFE Pharma, Harro Höfliger, and Sterling Partner to Provide Formulation Services for Respiratory Products
DFE Pharma, Harro Höfliger, and Sterling have announced a partnership called Inhalation Together to provide formulation services for respiratory products.
FDA and Congress Re-Examine Accelerated Approval Program
Congress is considering revising and improving policies related to drug development and regulation for possible inclusion in broader legislation to reauthorize FDA user fees.
Gamma Biosciences and Mirus Bio to Develop Lipid-Polymer Nanocomplexes
Gamma Biosciences has announced an initiative through its subsidiary, Mirus Bio, to develop lipid-polymer nanocomplexes for improve mRNA delivery solutions.
Roquette Invests €25 million for Polyols at its Site in Lestrem, France
Roquette is investing €25 million at its site in Lestrem, France to strengthen its position in the polyols market.
